Molecular markers of the risk of oral cancer

New England Journal of Medicine

Volumn 344, Issue 17, 2001, Pages 1323-1326

  Lippman, S M ^a   Waun Ki Hong, ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

CANCER RISK; DISEASE COURSE; DISEASE MARKER; DNA CONTENT; EARLY DIAGNOSIS; EDITORIAL; EPITHELIUM DYSPLASIA; HETEROZYGOSITY LOSS; HUMAN; LEUKOPLAKIA; MOLECULAR BIOLOGY; MOUTH CANCER; PRIORITY JOURNAL;

DNA, NEOPLASM; GENETIC MARKERS; HUMANS; LEUKOPLAKIA, ORAL; MOUTH NEOPLASMS; PLOIDIES; PROGNOSIS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035953705     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200104263441710     Document Type: Editorial

References (11)

1. Head and neck cancer
2. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia
3. DNA content as a prognostic marker in patients with oral leukoplakia
4. Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment
5. A case-control study confirms that microsatellite assay can identify patients at risk of developing oral squamous cell carcinoma within a field of cancerization
6. Predicting cancer development in oral leukoplakia: Ten years of translational research
7. Impact of localized treatment in reducing risk of progression of low-grade oral dysplasia: Molecular evidence of incomplete resection
8. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck
9. Multiple oral squamous epithelial lesions: Are they genetically related?
10. Cancer chemoprevention: Progress and promise
11. Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy